322 related articles for article (PubMed ID: 22127729)
21. Effects of age and body mass index on the results of transtrochanteric rotational osteotomy for femoral head osteonecrosis.
Ha YC; Kim HJ; Kim SY; Kim KC; Lee YK; Koo KH
J Bone Joint Surg Am; 2010 Feb; 92(2):314-21. PubMed ID: 20124057
[TBL] [Abstract][Full Text] [Related]
22. Influence of acetabular coverage on hip survival after free vascularized fibular grafting for femoral head osteonecrosis.
Roush TF; Olson SA; Pietrobon R; Braga L; Urbaniak JR
J Bone Joint Surg Am; 2006 Oct; 88(10):2152-8. PubMed ID: 17015591
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic decompression and bone grafting for small asymptomatic osteonecrotic lesions of the femoral head.
Hsu JE; Wihbey T; Shah RP; Garino JP; Lee GC
Hip Int; 2011; 21(6):672-7. PubMed ID: 22038309
[TBL] [Abstract][Full Text] [Related]
24. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.
Agarwala S; Shah S; Joshi VR
J Bone Joint Surg Br; 2009 Aug; 91(8):1013-8. PubMed ID: 19651826
[TBL] [Abstract][Full Text] [Related]
25. Comparison of early results of vascularized and non-vascularized fibular grafting in the treatment of osteonecrosis of the femoral head.
Tetik C; Başar H; Bezer M; Erol B; Ağir I; Esemenli T
Acta Orthop Traumatol Turc; 2011; 45(5):326-34. PubMed ID: 22032997
[TBL] [Abstract][Full Text] [Related]
26. Survivorship of femoral revision hip arthroplasty in patients with osteonecrosis.
Hungerford MW; Hungerford DS; Khanuja HS; Pietryak BP; Jones LC
J Bone Joint Surg Am; 2006 Nov; 88 Suppl 3():126-30. PubMed ID: 17079378
[TBL] [Abstract][Full Text] [Related]
27. High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head.
Xie K; Mao Y; Qu X; Dai K; Jia Q; Zhu Z; Yan M
J Orthop Surg Res; 2018 Feb; 13(1):25. PubMed ID: 29394948
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression.
Kang JS; Suh YJ; Moon KH; Park JS; Roh TH; Park MH; Ryu DJ
Stem Cell Res Ther; 2018 Oct; 9(1):274. PubMed ID: 30359323
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: A network meta-analysis of randomized controlled trials.
Yu X; Zhang D; Chen X; Yang J; Shi L; Pang Q
J Orthop Sci; 2018 Mar; 23(2):356-364. PubMed ID: 29291916
[TBL] [Abstract][Full Text] [Related]
30. Early Outcomes of Primary Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients with Human Immunodeficiency Virus in China.
Zhao CS; Li X; Zhang Q; Sun S; Zhao RG; Cai J
Chin Med J (Engl); 2015 Aug; 128(15):2059-64. PubMed ID: 26228219
[TBL] [Abstract][Full Text] [Related]
31. [Prevention for glucocorticoid-induced osteonecrosis of femoral head: a long-term clinical follow-up trail].
Liu BY; Yang L; Wang BJ; Wang ZH; Cheng LL; Xie H; Qiu X; Ma ZJ; Zhao DW
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3213-3218. PubMed ID: 29141357
[No Abstract] [Full Text] [Related]
32. A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty.
Iwamoto N; Inaba Y; Kobayashi N; Ishida T; Yukizawa Y; Saito T
J Bone Joint Surg Am; 2011 Jul; 93(13):1203-9. PubMed ID: 21776573
[TBL] [Abstract][Full Text] [Related]
33. Histologic analysis of acetabular and proximal femoral bone in patients with osteonecrosis of the femoral head.
Kim YH; Kim JS
J Bone Joint Surg Am; 2004 Nov; 86(11):2471-4. PubMed ID: 15523020
[TBL] [Abstract][Full Text] [Related]
34. Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head.
Chen CC; Lin CL; Chen WC; Shih HN; Ueng SW; Lee MS
J Bone Joint Surg Am; 2009 Oct; 91(10):2390-4. PubMed ID: 19797574
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study.
Agarwala S; Jain D; Joshi VR; Sule A
Rheumatology (Oxford); 2005 Mar; 44(3):352-9. PubMed ID: 15572396
[TBL] [Abstract][Full Text] [Related]
36. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment.
Neumayr LD; Aguilar C; Earles AN; Jergesen HE; Haberkern CM; Kammen BF; Nancarrow PA; Padua E; Milet M; Stulberg BN; Williams RA; Orringer EP; Graber N; Robertson SM; Vichinsky EP;
J Bone Joint Surg Am; 2006 Dec; 88(12):2573-82. PubMed ID: 17142406
[TBL] [Abstract][Full Text] [Related]
37. Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty.
Arabmotlagh M; Pilz M; Warzecha J; Rauschmann M
J Orthop Res; 2009 Feb; 27(2):183-8. PubMed ID: 18752281
[TBL] [Abstract][Full Text] [Related]
38. High Pelvic Incidence Is Associated with Disease Progression in Nontraumatic Osteonecrosis of the Femoral Head.
Kwon HM; Yang IH; Park KK; Cho BW; Kam JH; Kong Y; Yang JH; Lee WS
Clin Orthop Relat Res; 2020 Aug; 478(8):1870-1876. PubMed ID: 32732569
[TBL] [Abstract][Full Text] [Related]
39. [Surface-replacement total hip arthroplasty in the treatment of the femoral head osteonecrosis].
Yu Z; Wang LM; Gui JC; Wu JX; Jiang CZ; Xu Y
Zhongguo Gu Shang; 2008 Jan; 21(1):35-7. PubMed ID: 19102270
[TBL] [Abstract][Full Text] [Related]
40. [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study].
Nehme A; Maalouf G; Tricoire JL; Giordano G; Chiron P; Puget J
Rev Chir Orthop Reparatrice Appar Mot; 2003 Nov; 89(7):593-8. PubMed ID: 14699304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
